A Metabolic Disease Posing Severe Pancreatic Risks Gets Its First FDA-Approved Therapy

Ionis Pharmaceuticals’ Tryngolza is now the first approved therapy for treating severe hypertriglyceridemia, a prevalent chronic metabolic disorder that can lead to acute pancreatitis. This drug is a key piece of Ionis’s pivot away from partnering its assets, and instead developing and commercializing them on its own. The post A Metabolic Disease Posing Severe Pancreatic…

Read More

Quantifying the Lifetime Economic Impact of Pediatric Oral Nutritional Supplements

That is the title of a new paper published this week in Clinical Nutrition with co-authors Kyi-Sin Than, Khounish Sharma, Kirk W. Kerr, and Dhanasekhar Kesavelu. The abstract is below: IntroductionPediatric malnutrition is a significant global public health challenge, particularly in low- and middle-income countries. This study quantifies the lifetime, per-person economic impact of pediatric…

Read More

2025 Nobel Prize in Economics goes to…

Joel Mokyr, Philippe Aghion and Peter Howitt. The Nobel Prize committee said that the award was merited “for having identified the prerequisites for sustained growth through technological progress” The Nobel Prize committee summarizes their key contributions as follows: Over the last two centuries, for the first time in history, the world has seen sustained economic…

Read More

IVF Coverage Proposals Could Squeeze U.S. Fertility Clinics Without Improving Access

Ideas floated by the Trump Administration and Democrats in Congress aim to expand access to fertility treatment as an essential health benefit. But an influx of patients could collide with an already-brittle system of 430,000 annual cycles, 5,000 embryologists, and long-overdue lab upgrades. The post IVF Coverage Proposals Could Squeeze U.S. Fertility Clinics Without Improving…

Read More